How Money Fuels New Drug Development: A Pharmacist’s Perspective
Creating new medicines is a costly and uncertain process. For small biotechnology companies just starting out, it can take many […]
Creating new medicines is a costly and uncertain process. For small biotechnology companies just starting out, it can take many […]
SAN FRANCISCO — Many deals in the biopharmaceutical industry often start at the annual J.P. Morgan Healthcare conference. Young biotech
STORM Therapeutics has joined forces with AlidaBio, a US-based company, to speed up the development of new cancer treatments that
Aktis Oncology, a company that makes special drugs to treat cancer, announced on Thursday that it raised $318 million from
Here’s a simple rundown of recent news from several pharmaceutical companies. Insmed reported that their new drug, Brinsupri, which treats
In 2025, the Food and Drug Administration (FDA) approved 46 new medicines. This is fewer than the previous two years
Biogen, a major pharmaceutical company, is undergoing significant changes. They’re moving to a new headquarters near Boston and expanding beyond
In both studies, mepolizumab, when added to triple therapy, showed significant reductions in flare-up rates compared to a placebo and
In a year filled with ups and downs, there’s a noticeable difference in how pharmaceutical leaders in the U.S. and
The Food and Drug Administration (FDA) has recently approved a new pill version of the weight loss drug Wegovy, made